1. Home
  2. WW vs IMUX Comparison

WW vs IMUX Comparison

Compare WW & IMUX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WW
  • IMUX
  • Stock Information
  • Founded
  • WW 1961
  • IMUX 2016
  • Country
  • WW United States
  • IMUX United States
  • Employees
  • WW N/A
  • IMUX N/A
  • Industry
  • WW Other Consumer Services
  • IMUX Biotechnology: Pharmaceutical Preparations
  • Sector
  • WW Consumer Discretionary
  • IMUX Health Care
  • Exchange
  • WW Nasdaq
  • IMUX Nasdaq
  • Market Cap
  • WW 75.9M
  • IMUX 86.3M
  • IPO Year
  • WW 2001
  • IMUX N/A
  • Fundamental
  • Price
  • WW $0.92
  • IMUX $0.95
  • Analyst Decision
  • WW Buy
  • IMUX Strong Buy
  • Analyst Count
  • WW 5
  • IMUX 6
  • Target Price
  • WW $3.44
  • IMUX $12.67
  • AVG Volume (30 Days)
  • WW 2.8M
  • IMUX 1.0M
  • Earning Date
  • WW 02-26-2025
  • IMUX 02-20-2025
  • Dividend Yield
  • WW N/A
  • IMUX N/A
  • EPS Growth
  • WW N/A
  • IMUX N/A
  • EPS
  • WW N/A
  • IMUX N/A
  • Revenue
  • WW $807,465,000.00
  • IMUX N/A
  • Revenue This Year
  • WW N/A
  • IMUX N/A
  • Revenue Next Year
  • WW N/A
  • IMUX N/A
  • P/E Ratio
  • WW N/A
  • IMUX N/A
  • Revenue Growth
  • WW N/A
  • IMUX N/A
  • 52 Week Low
  • WW $0.67
  • IMUX $0.92
  • 52 Week High
  • WW $5.22
  • IMUX $2.11
  • Technical
  • Relative Strength Index (RSI)
  • WW 39.73
  • IMUX 41.06
  • Support Level
  • WW $1.03
  • IMUX $0.93
  • Resistance Level
  • WW $1.19
  • IMUX $1.02
  • Average True Range (ATR)
  • WW 0.09
  • IMUX 0.07
  • MACD
  • WW -0.02
  • IMUX 0.00
  • Stochastic Oscillator
  • WW 2.94
  • IMUX 27.01

About WW WW International Inc.

WW International Inc is a provider of weight loss solutions. The firm offers its members access to in person workshops and digital solutions as a part of its weight loss and weight management programs. Its digital app provides members access to tools such as, trackers for food, water, activity, weight, content regarding behavioral techniques for building healthy habits and other related tools. Along with its in person workshops and digital solutions, the company also provides members who medically qualify access to clinicians who can prescribe weight management medications when clinically appropriate. The company generates majority of its revenue in the form of Subscription Revenue. Geographically, the company generates key revenue from North America and rest from International markets.

About IMUX Immunic Inc.

Immunic Inc is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis. The company is developing small molecule products, which include IMU-838, which is a selective immune modulator that inhibits the intracellular metabolism of activated immune cells by blocking the enzyme DHODH; IMU-935 is an inverse agonist of RORyt, and IMU-856 targets the restoration of the intestinal barrier function.

Share on Social Networks: